WEHI-P8

WEHI-P8
Please request pricing for this article.
Request Pricing

Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T207007-10mg 10 mg - - -

7 - 10 business days*

-
TGM-T207007-50mg 50 mg - - -

7 - 10 business days*

-
 
Description: WEHI-P8 is an orally active inhibitor targeting the coronavirus papain-like protease... more
Product information "WEHI-P8"
Description: WEHI-P8 is an orally active inhibitor targeting the coronavirus papain-like protease (PLpro). It inhibits SARS-CoV-2 PLpro with an IC50 of 12 nM and demonstrates excellent cellular activity with an EC50 of 298 nM. Additionally, WEHI-P8 has protective effects in mice against prolonged lung and brain symptoms caused by SARS-CoV-2. This compound is applicable for research on post-COVID-19 syndrome. Target: SARS-CoV
Supplier: TargetMol
Supplier-Nr: T207007

Properties

Database Information

Handling & Safety

Storage: +4°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "WEHI-P8"
Write a review
or to review a product.
Viewed